AndroGel (testosterone gel), manufactured by AbbVie, can thicken the blood and increase the risk of blood clots, which may cause a heart attack, stroke, pulmonary embolism, or even death.
UPDATE: Canadian Lawyers file AndroGel Class Action Lawsuit
July 25, 2014 — Attorneys in Canada have filed an AndroGel class action against AbbVie, seeking recovery on behalf of Canadians who purchased testosterone products. Click here to read more.
AndroGel Safety Concerns
In a Safety Communication published in January 2014, the U.S. Food and Drug Administration (FDA) warned about two studies linking testosterone replacement therapy to heart attacks, strokes, and death. One study found that these events were 30% more likely in the first 90 days of treatment, and another study found a doubled risk of heart attack for men over 65 on testosterone.
The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs' law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm's reputation for providing personal attention to each and every client we represent.
